Transient Receptor Potential Channels Contribute to Pathological Structural and Functional Remodeling After Myocardial Infarction
暂无分享,去创建一个
S. Houser | M. Madesh | J. Molkentin | E. Gao | Catherine A Makarewich | Robert N. Correll | Constantine D. Troupes | Xiongwen Chen | H. Kubo | Catherine A. Makarewich | N. Hoffman | Hongyu Zhang | R. Berretta | Danielle M. Trappanese | Jennifer Davis | Remus M. Berretta | C. Makarewich
[1] D. Kass,et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.
[2] D. Kass,et al. Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP–Protein Kinase G Modulation , 2014, Circulation research.
[3] J. Cheung,et al. MICU1 motifs define mitochondrial calcium uniporter binding and activity. , 2013, Cell reports.
[4] C. Romanin,et al. Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca2+ entry pathways , 2012, British journal of pharmacology.
[5] S. Houser,et al. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. , 2012, Journal of molecular and cellular cardiology.
[6] M. Birnbaum,et al. MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival , 2012, Cell.
[7] S. Houser,et al. A Characterization and Targeting of the Infarct Border Zone in a Swine Model of Myocardial Infarction , 2012, Clinical and translational science.
[8] S. Houser,et al. Hyperphosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Is Not Involved in Cardiac Dysfunction After Myocardial Infarction , 2012, Circulation research.
[9] S. Houser,et al. A Caveolae-Targeted L-Type Ca2+ Channel Antagonist Inhibits Hypertrophic Signaling Without Reducing Cardiac Contractility , 2012, Circulation research.
[10] J. Xie,et al. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart , 2012, Nature Communications.
[11] H. Cingolani,et al. In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy , 2011, Pflügers Archiv - European Journal of Physiology.
[12] C. Romanin,et al. PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes , 2011, Proceedings of the National Academy of Sciences.
[13] David M. Harris,et al. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. , 2011, Journal of molecular and cellular cardiology.
[14] A. Beck,et al. Transient receptor proteins illuminated: current views on TRPs and disease. , 2011, Veterinary journal.
[15] J. Molkentin,et al. TRPC Channels As Effectors of Cardiac Hypertrophy , 2011, Circulation Research.
[16] W. Koch,et al. A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse , 2010, Circulation research.
[17] David M. Harris,et al. Increasing Cardiac Contractility After Myocardial Infarction Exacerbates Cardiac Injury and Pump Dysfunction , 2010, Circulation research.
[18] S. Houser,et al. Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity. , 2010, American journal of physiology. Heart and circulatory physiology.
[19] K. Nakao,et al. Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart , 2010, Circulation research.
[20] J. Molkentin,et al. TRPC channels are necessary mediators of pathologic cardiac hypertrophy , 2010, Proceedings of the National Academy of Sciences.
[21] L. Birnbaumer,et al. TRPC1 Channels Are Critical for Hypertrophic Signaling in the Heart , 2009, Circulation research.
[22] R. Sandford,et al. The Transient Receptor Potential Channels TRPP2 and TRPC1 Form a Heterotetramer with a 2:2 Stoichiometry and an Alternating Subunit Arrangement , 2009, The Journal of Biological Chemistry.
[23] J. Levine,et al. TRPC1 and TRPC6 Channels Cooperate with TRPV4 to Mediate Mechanical Hyperalgesia and Nociceptor Sensitization , 2009, The Journal of Neuroscience.
[24] M. Nishida,et al. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound , 2009, Proceedings of the National Academy of Sciences.
[25] L. Birnbaumer,et al. Physiology and pathophysiology of canonical transient receptor potential channels , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] S. Houser,et al. Ca2+ Influx Through T- and L-Type Ca2+ Channels Have Different Effects on Myocyte Contractility and Induce Unique Cardiac Phenotypes , 2008, Circulation research.
[27] Youjun Wang,et al. STIM, ORAI AND TRPC CHANNELS IN THE CONTROL OF CALCIUM ENTRY SIGNALS IN SMOOTH MUSCLE , 2008, Clinical and experimental pharmacology & physiology.
[28] David M. Harris,et al. Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation. , 2008, American journal of physiology. Heart and circulatory physiology.
[29] V. Rizzo,et al. Endothelial cytoskeletal reorganization in response to PAR1 stimulation is mediated by membrane rafts but not caveolae. , 2007, American journal of physiology. Heart and circulatory physiology.
[30] H. Cingolani,et al. Phosphodiesterase 5A Inhibition Induces Na+/H+ Exchanger Blockade and Protection Against Myocardial Infarction , 2007, Hypertension.
[31] T. O’Connell,et al. Isolation and culture of adult mouse cardiac myocytes. , 2007, Methods in molecular biology.
[32] Y. Mori,et al. Upregulation of TRPC1 in the development of cardiac hypertrophy. , 2006, Journal of molecular and cellular cardiology.
[33] E. Olson,et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. , 2006, The Journal of clinical investigation.
[34] M. Nishida,et al. TRPC3 and TRPC6 are essential for angiotensin II‐induced cardiac hypertrophy , 2006, The EMBO journal.
[35] E. Olson,et al. Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling* , 2006, Journal of Biological Chemistry.
[36] H. Nakayama,et al. Calcineurin‐dependent cardiomyopathy is activated by TRPC in the adult mouse heart , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] J. Molkentin,et al. Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.
[38] H. Kahr,et al. TRPC3 and TRPC4 Associate to Form a Redox-sensitive Cation Channel , 2006, Journal of Biological Chemistry.
[39] B. Aronow,et al. Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice* , 2006, Journal of Biological Chemistry.
[40] Benjamin R. Rost,et al. The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance , 2005, Pflügers Archiv.
[41] M. Lisanti,et al. Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.
[42] P. Davies,et al. Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. , 2003, American journal of physiology. Heart and circulatory physiology.
[43] Q. Liang,et al. Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.
[44] S. Houser,et al. Sodium and the heart: a hidden key factor in cardiac regulation. , 2003, Cardiovascular research.
[45] Steven R Houser,et al. Is depressed myocyte contractility centrally involved in heart failure? , 2003, Circulation research.
[46] T. Gudermann,et al. Subunit composition of mammalian transient receptor potential channels in living cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] D. Bers. Cardiac Na/Ca exchange function in rabbit, mouse and man: what's the difference? , 2002, Journal of molecular and cellular cardiology.
[48] D. Bers. Calcium and cardiac rhythms: physiological and pathophysiological. , 2002, Circulation research.
[49] S. Houser,et al. Patients With End-Stage Congestive Heart Failure Treated With &bgr;-Adrenergic Receptor Antagonists Have Improved Ventricular Myocyte Calcium Regulatory Protein Abundance , 2001, Circulation.
[50] D. Clapham,et al. The trp ion channel family , 2001, Nature Reviews Neuroscience.
[51] R. Bush,et al. Predicting adaptive evolution , 2001, Nature Reviews Genetics.
[52] S. Houser,et al. Abnormalities of calcium cycling in the hypertrophied and failing heart. , 2000, Journal of molecular and cellular cardiology.
[53] K. Chien. Meeting Koch's postulates for calcium signaling in cardiac hypertrophy. , 2000, The Journal of clinical investigation.
[54] G. Condorelli,et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. , 2000, Circulation research.
[55] P. Oh,et al. Immunoisolation of Caveolae with High Affinity Antibody Binding to the Oligomeric Caveolin Cage , 1999, The Journal of Biological Chemistry.
[56] E. Olson,et al. Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? , 1999, Circulation research.
[57] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[58] T. Doetschman,et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. , 1994, Circulation research.
[59] S. Houser,et al. Sarcoplasmic reticulum-related changes in cytosolic calcium in pressure-overload-induced feline LV hypertrophy. , 1993, The American journal of physiology.
[60] W. Lederer,et al. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. , 1993, Science.
[61] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[62] S. Houser,et al. Voltage and beat dependence of Ca2+ transient in feline ventricular myocytes. , 1989, The American journal of physiology.
[63] S. Houser,et al. Isolation and morphology of calcium-tolerant feline ventricular myocytes. , 1983, The American journal of physiology.
[64] J. Koch-weser,et al. THE INFLUENCE OF THE INTERVAL BETWEEN BEATS ON MYOCARDIAL CONTRACTILITY. , 1963, Pharmacological reviews.
[65] W. Koch,et al. A novel and efficient model of coronary artery ligation in the mouse. , 2013, Methods in molecular biology.
[66] W. Lederer,et al. Calcium sparks. , 2008, Physiological reviews.
[67] J. A. Peters,et al. Transient receptor potential cation channels in disease. , 2007, Physiological reviews.
[68] G. Lamas,et al. Ventricular remodeling after myocardial infarction. , 1993, Advances in experimental medicine and biology.
[69] S. Houser,et al. Contractile properties of single isolated feline ventriculocytes. , 1988, The American journal of physiology.